Advanced therapies: research and development

The European Medicines Agency (EMA) provides guidance and support to companies researching, developing and manufacturing advanced therapy medicinal products (ATMPs). This includes scientific and regulatory guidance, compliance standards as well as incentives for companies developing ATMPs.

In this section

• Support for advanced-therapy developers
• Certification procedures for advanced therapies under development by micro-, small- and medium-sized enterprises (SMEs)
• Guidelines relevant for advanced therapy medicinal products